Lisdexamfetamine Dimesylate NDC 70010-206

NDC codes

FDA NDC Directory

Product NDC (as listed)70010-206Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70010-0206Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70010-206-01	70010020601	100 CAPSULE in 1 BOTTLE (70010-206-01)Marketed from Jan 29, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lisdexamfetamine Dimesylate
Generic name (nonproprietary): lisdexamfetamine dimesylate
Active ingredients: Lisdexamfetamine dimesylate — 10 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Granules Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218987
Marketing start: Jan 29, 2025
Listing expires: Dec 31, 2027
DEA schedule: CII
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)
Identifiers: Product ID 70010-206_51ac69ee-5739-024f-e063-6394a90a3179SPL ID 51ac69ee-5739-024f-e063-6394a90a3179SPL set ID c91c6acf-b68c-4832-a06f-d0fbd6b80457RxCUI 854830, 854834, 854838, 854842, 854846, 854850, 1593856UNII SJT761GEGSUPC 0370010211018, 0370010206014, 0370010207011, 0370010209015, 0370010212015, 0370010208018
Pharmacologic class: Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470010020601 followed by a unit qualifier and the quantity

Package 70010-0206-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 218987

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218987
Product	Strength	Form · route	Labeler	Product NDC
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 30 mg/1	CapsuleOral	Granules Pharmaceuticals Inc.	70010-208
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 20 mg/1	CapsuleOral	Granules Pharmaceuticals Inc.	70010-207
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 70 mg/1	CapsuleOral	Granules Pharmaceuticals Inc.	70010-212
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 40 mg/1	CapsuleOral	Granules Pharmaceuticals Inc.	70010-209
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 50 mg/1	CapsuleOral	Granules Pharmaceuticals Inc.	70010-210
Lisdexamfetamine Dimesylate	Lisdexamfetamine dimesylate 60 mg/1	CapsuleOral	Granules Pharmaceuticals Inc.	70010-211